These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9382373)

  • 41. Discontinuation of primary prophylaxis against Mycobacterium avium complex infection in HIV-infected persons receiving antiretroviral therapy: observations from a large national cohort in the United States, 1992-2002.
    Brooks JT; Song R; Hanson DL; Wolfe M; Swerdlow DL;
    Clin Infect Dis; 2005 Aug; 41(4):549-53. PubMed ID: 16028167
    [TBL] [Abstract][Full Text] [Related]  

  • 42. From the Centers for Disease Control and Prevention. Draft of Guidelines for the Prevention of Opportunistic Infections (OIs) in persons infected with human immunodeficiency virus.
    JAMA; 2001 Sep; 286(11):1308. PubMed ID: 11575326
    [No Abstract]   [Full Text] [Related]  

  • 43. PHS guidelines on opportunistic infections. US Public Health Service.
    Proj Inf Perspect; 1997 Nov; (23):12-4. PubMed ID: 11365371
    [TBL] [Abstract][Full Text] [Related]  

  • 44. What's new in the 2009 US guidelines for prevention and treatment of opportunistic infections among adults and adolescents with HIV?
    Brooks JT; Kaplan JE; Masur H
    Top HIV Med; 2009; 17(3):109-14. PubMed ID: 19675369
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prevention of opportunistic infections in HIV-infected adults].
    Furrer H; Malinverni R
    Ther Umsch; 1998 May; 55(5):302-9. PubMed ID: 9643128
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prophylaxis for opportunistic infections in an era of effective antiretroviral therapy.
    Powderly WG
    Clin Infect Dis; 2000 Aug; 31(2):597-601. PubMed ID: 10987727
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Salmonellosis in persons infected with human immunodeficiency virus: a report of seven cases from Malaysia.
    Puthucheary SD; Ng KP; Hafeez A; Raja NS; Hassan HH
    Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):361-5. PubMed ID: 15691137
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Opportunistic infections: stemming the tide.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1997 Apr; 3(4):42-7. PubMed ID: 11364202
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment and prophylaxis of the principal infections associated with the human immunodeficiency virus].
    Valencia E; Soriano V; González-Lahoz J
    Med Clin (Barc); 1993 Oct; 101(13):505-14. PubMed ID: 8231387
    [No Abstract]   [Full Text] [Related]  

  • 50. Prophylaxis with trimethoprim-sulfamethoxazole for human immunodeficiency virus-infected patients: impact on risk for infectious diseases.
    Dworkin MS; Williamson J; Jones JL; Kaplan JE;
    Clin Infect Dis; 2001 Aug; 33(3):393-8. PubMed ID: 11438910
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Hepatitis B vaccine in patients with human immunodeficiency virus infection].
    Ramírez O CA; Fernández A DG; Valderrama B SL; Gómez Q CH; Támara R JR; Alvarez M CA
    Rev Chilena Infectol; 2009 Feb; 26(1):26-33. PubMed ID: 19350156
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CDC updates opportunistic disease prevention guidelines.
    AIDS Policy Law; 2002 Jul; 17(12):3. PubMed ID: 12134795
    [No Abstract]   [Full Text] [Related]  

  • 53. HIV-associated opportunistic infections--going, going, but not gone: the continued need for prevention and treatment guidelines.
    Brooks JT; Kaplan JE; Holmes KK; Benson C; Pau A; Masur H
    Clin Infect Dis; 2009 Mar; 48(5):609-11. PubMed ID: 19191648
    [No Abstract]   [Full Text] [Related]  

  • 54. Indicators for assessment of compliance with quality standards for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.
    Gross PA; Kaplan JE; Phair JP; Masur H; Wilfert CM; Holmes KK
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S138-41. PubMed ID: 8547509
    [No Abstract]   [Full Text] [Related]  

  • 55. Influenza A among patients with human immunodeficiency virus: an outbreak of infection at a residential facility in New York City.
    Fine AD; Bridges CB; De Guzman AM; Glover L; Zeller B; Wong SJ; Baker I; Regnery H; Fukuda K
    Clin Infect Dis; 2001 Jun; 32(12):1784-91. PubMed ID: 11360221
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Performance measures for guidelines on preventing opportunistic infections in patients infected with human immunodeficiency virus.
    Gross PA; Asch S; Kitahata MM; Freedberg KA; Barr D; Melnick DA; Bozzette SA
    Clin Infect Dis; 2000 Apr; 30 Suppl 1():S85-93. PubMed ID: 10770917
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Opportunistic infections update.
    Proj Inf Perspect; 1999 Sep; (28):11-3. PubMed ID: 11367355
    [TBL] [Abstract][Full Text] [Related]  

  • 58. How human immunodeficiency virus voluntary testing can contribute to tuberculosis control.
    Godfrey-Faussett P; Maher D; Mukadi YD; Nunn P; Perriëns J; Raviglione M
    IAPAC Mon; 2003 Mar; 9(3):54-60. PubMed ID: 12744196
    [No Abstract]   [Full Text] [Related]  

  • 59. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determinants of antimicrobial prophylaxis use and treatment for wasting among patients with advanced human immunodeficiency virus disease in the United States, 1995-1998.
    Murphy EL; Assmann SF; Collier AC; Flanigan TP; Kumar PN; Wallach FR; Krubel S
    Clin Infect Dis; 2001 Jan; 32(1):116-23. PubMed ID: 11118390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.